Table 3.
MS score |
P-value | |||||
---|---|---|---|---|---|---|
0 (n = 6) | 1 (n = 25) | 2 (n = 47) | 3 (n = 39) | 4 (n = 25) | ||
GFR-epia | 48.1 ± 16.1 | 35.2 ± 24.7 | 36.5 ± 18.5 | 36.9 ± 18.8 | 25.6 ± 10.4b,c,d | |
Leptin | 8.5 ± 16.5 | 9.5 ± 22.3 | 23.1 ± 34.4e | 42 ± 37b,c,e | 47.3 ± 38.4b,c,e | <0.001 |
TAdip | 8.8 ± 6.1 | 14.3 ± 6.5b | 10.5 ± 5.5e | 8.8 ± 4e | 10 ± 6.9e | 0.006 |
HMWAdip | 4.3 ± 4.1 | 7.8 ± 4.6b | 5.3 ± 3.6e | 4.1 ± 2.4e | 5.8 ± 6e | 0.014 |
Insulin | 14.8 ± 9.9 | 17.1 ± 13.8 | 25.8 ± 22.2e | 37.2 ± 26.6b,c,e | 38.9 ± 22.9b,c,e | <0.001 |
aCalculated for patients at CKD stages 2–5 (n = 96). For units, please see Table 2.
b0 versus 1, 3, 4, P < 0,05.
c2 versus 3, 4, P < 0,05.
d3 versus 4, P < 0,05.
e1 versus 2, 3, 4, P < 0,05;
GFR, glomerular filtration rate; TAdip, total adiponectin; HMWAdip, high-molecular weight adiponectin.